DIFFERENT FREQUENCIES OF ANGIOTENSIN-CONVERTING ENZYME GENOTYPES IN OLDER HYPERTENSIVE INDIVIDUALS

被引:130
作者
MORRIS, BJ
ZEE, RYL
SCHRADER, AP
机构
[1] Department of Physiology, School of Medicine, University of Sydney
[2] School of Medicine, Building F13, University of Sydney
关键词
CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; SURVIVAL;
D O I
10.1172/JCI117423
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The frequency of the D allele of an insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene has been reported to be elevated in myocardial infarction and other patients. We therefore hypothesized that death rate of DD individuals should be increased in the population as a whole and this should be evident as a decrease in DD frequency with age. This hypothesis was tested in 118 Caucasian subjects who were already at high risk of cardiovascular events by having severe, early onset, familiar hypertension (HT). A group of 196 age-, sex- and body mass index-matched normotensives (NTs) was used as a control. In the NT group II, ID, and DD genotype frequencies were similar for different age groups. DD frequency was 0.42 in NTs, but in HTs was 0.28, 0.26, and 0.10 for the age groups < 50, 50-59, and greater than or equal to 60 yr, respectively. Corresponding D allele frequencies were 0.52, 0.46, and 0.40 in the respective age groups of HTs, compared with 0.61 in NTs (by chi(2)-analysis, P = 0.1, 0.047, and 0.0006, respectively). In HTs aged greater than or equal to 60, DD frequency was only 14% of expected. Plasma ACE activity tracked similarly with IID genotype in HTs (P = 0.027; n = 35) as in NTs (P = 0.0001; n = 94) and Michaelis constant was identical for DD and II. Neither blood pressure, body mass index, nor sex bore any relationship with I/D genotype, In conclusion, in a group of severely HT patients not selected for cardiac pathology, there appeared to be a marked, selective decrease, in subgroups of increasing age, in frequency of the ACE DD genotype. One possibility suggested by this data might be that DD increases risk of premature death, at least in HTs who have two HT parents.
引用
收藏
页码:1085 / 1089
页数:5
相关论文
共 50 条
  • [41] Ongoing trials of angiotensin-converting enzyme inhibition: What they can tell us
    Chalmers, JP
    AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (08) : 270S - 275S
  • [42] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF CLINICAL HEART-FAILURE
    POULEUR, H
    BASIC RESEARCH IN CARDIOLOGY, 1993, 88 : 203 - 209
  • [43] EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON MITOCHONDRIAL NUMBER IN THE AGING MOUSE
    FERDER, L
    INSERRA, F
    ROMANO, L
    ERCOLE, L
    PSZENNY, V
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01): : C15 - C18
  • [44] Is There an Association between Angiotensin Converting Enzyme (ACE) Genotypes and Abdominal Aortic Aneurysm?
    Obukofe, B.
    Sayers, R. D.
    Thompson, J.
    Sandford, R. M.
    London, N. J. M.
    Samani, N. J.
    Bown, M. J.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2010, 40 (04) : 457 - 460
  • [45] Angiotensin-Converting Enzyme (ACE) Gene Polymorphisms are Associated with Idiopathic Pulmonary Fibrosis
    Uh, Soo-Taek
    Kim, Tae-Hoon
    Shim, Eun-Young
    Jang, An-Soo
    Park, Sung-Woo
    Park, Jong-Sook
    Park, Byung-Lae
    Choi, Byoung Whui
    Shin, Hyoung Doo
    Kim, Dong Soon
    Park, Choon-Sik
    LUNG, 2013, 191 (04) : 345 - 351
  • [46] Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention
    Ann, Soe Hee
    Strauss, Martin H.
    Park, Gyung-Min
    Han, Seungbong
    Yang, Yujin
    Kim, Yong-Giun
    Won, Ki-Bum
    Kim, Shin-Jae
    Lee, Sang-Gon
    Cho, Young-Rak
    Kim, Dae-Won
    Park, Mahn-Won
    Her, Sung Ho
    Lee, Seung-Whan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 35 - 41
  • [47] Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
    Molnar, Miklos Z.
    Kalantar-Zadeh, Kamyar
    Lott, Evan H.
    Lu, Jun Ling
    Malakauskas, Sandra M.
    Ma, Jennie Z.
    Quarles, Darryl L.
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 650 - 658
  • [48] Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer
    Wittayanukorn, Saranrat
    Qian, Jingjing
    Westrick, Salisa C.
    Billor, Nedret
    Johnson, Brandon
    Hansen, Richard A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (09): : 909 - 918
  • [49] Emerging markers in cardiovascular disease: Where does angiotensin-converting enzyme 2 fit in?
    Patel, Sheila K.
    Velkoska, Elena
    Burrell, Louise M.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 (08) : 551 - 559
  • [50] Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use
    Byrd, J. B.
    Woodard-Grice, A.
    Stone, E.
    Lucisano, A.
    Schaefer, H.
    Yu, C.
    Eyler, A. E.
    Salloum, N. E.
    Brown, N. J.
    ALLERGY, 2010, 65 (11) : 1381 - 1387